Perlecan Fragments as Biomarkers of Bone Stromal Lysis
A method for the detection in a body fluid of perlecan polypeptide fragments that are biomarkers of tumor metastasis, and antibodies for detecting these fragments are described. An immunoassay kit for detecting the presence of these biomarkers in a body fluid, such as serum or urine, is also described.
FARACH-CARSON MARY C [US]
Type of Offer:
« More Biotech Patents